Stages of ckd
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Stages of Chronic Kidney Disease (CKD)
Overview of CKD Stages
Chronic Kidney Disease (CKD) is a progressive condition characterized by a gradual loss of kidney function over time. It is classified into five stages based on the estimated glomerular filtration rate (eGFR) and the presence of kidney damage markers such as albuminuria. Each stage represents a different level of kidney function and associated health risks.
Stage 1 and Stage 2 CKD: Early Stages
Characteristics and Prevalence
Stage 1 CKD is defined by an eGFR greater than 90 mL/min/1.73 m² with evidence of kidney damage, such as albuminuria. Stage 2 CKD is characterized by an eGFR between 60-89 mL/min/1.73 m², also with evidence of kidney damage. These early stages are often asymptomatic and can go undiagnosed without routine screening .
Cardiovascular Risks
Despite being early stages, CKD stages 1 and 2 are associated with increased cardiovascular risks, especially when proteinuria is present. Patients with stage 2 CKD without proteinuria have a comparable prognosis to those with normal renal function, whereas those with proteinuria face significantly higher risks of major adverse cardiovascular events (MACE) and heart failure.
Stage 3 CKD: Moderate Decline in Kidney Function
Characteristics and Prevalence
Stage 3 CKD is divided into two sub-stages: 3A (eGFR 45-59 mL/min/1.73 m²) and 3B (eGFR 30-44 mL/min/1.73 m²). This stage is more prevalent globally, with an estimated prevalence of 7.6%. In low- and middle-income countries in Asia, the prevalence of stages 3-5 CKD is around 11.2%.
Health Implications
Patients in stage 3 CKD often begin to experience symptoms such as fatigue, swelling, and changes in urination. This stage is critical for intervention to slow disease progression and manage complications .
Stage 4 CKD: Severe Decline in Kidney Function
Characteristics and Prevalence
Stage 4 CKD is defined by an eGFR between 15-29 mL/min/1.73 m². It is less common, with a global prevalence of about 0.4%. Patients in this stage often experience significant symptoms and complications, including anemia, bone disease, and cardiovascular issues.
Management Strategies
Effective management in stage 4 CKD includes preparing for potential renal replacement therapy, such as dialysis or transplantation. Augmented nurse care management has been shown to reduce hospitalization rates and improve preparation for end-stage kidney disease.
Stage 5 CKD: Kidney Failure
Characteristics and Prevalence
Stage 5 CKD, also known as end-stage renal disease (ESRD), is characterized by an eGFR of less than 15 mL/min/1.73 m². This stage has a global prevalence of about 0.1%. Patients in this stage require dialysis or a kidney transplant to survive.
Cardiovascular Complications
Cardiovascular complications are the leading cause of death in patients with stage 5 CKD. These include coronary artery disease, heart failure, and arrhythmias. The high mortality rate underscores the importance of early detection and management of CKD to prevent progression to this stage.
Conclusion
CKD progresses through five stages, each with distinct characteristics and health implications. Early stages (1 and 2) are often asymptomatic but carry cardiovascular risks, especially with proteinuria. Stage 3 is more prevalent and marks the onset of noticeable symptoms. Stage 4 requires intensive management to prepare for renal replacement therapy, while stage 5 necessitates dialysis or transplantation. Understanding these stages is crucial for timely intervention and improving patient outcomes.
Sources and full results
Most relevant research papers on this topic